TS03 Inc Trust Units TSTIF

RE:VP4 Beneficial to all Stakeholders

[binjo222]

Drrwong, a concise and insightful evaluation of TSO3's edge over the competition.

The catalyst for the markets begin to to recognize your thesis will probably be the FDA's granting the extended claims on sterilization of the Olympus and Pentax duodenscopes.  Reducing legal liability gets the attention of hoispital administrators.  (I used to work in a medical center on the administrative side.)

Until then, unfortunately, we are subject to the half-truths of Axler and those like him who feed on investors who only read the headlines.  TSO3 requires some knowledge of the 'hospital industry' to understand its real value.